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Women and men with coronary heart disease in three countries. Are they treated 
differently? 
 
Abstract 
Non-medical determinants of medical decision making were investigated in an international 
research project in the US, in the UK and in Germany. The key question in this paper is 
whether and to what extent doctors' diagnostic and therapeutic decisions in coronary heart 
disease (CHD) are influenced by the patients' gender. 
A factorial experiment with a videotaped patient consultation was conducted. Professional 
actors played the role of patients with symptoms of CHD. Several alternative versions were 
taped featuring the same script with patient-actors of different sex, age, race and socio-
economic status. The videotapes were presented to a randomly selected sample of 128 
primary care physicians in each country. Using an interview with standardized and open-
ended questions, physicians were asked how they would diagnose and treat such a patient 
after they had seen the video.  
Results show gender differences in the diagnostic strategies of the doctors. Women were 
asked different questions, a CHD was mentioned more often as a possible diagnosis for men 
than for women, and physicians were less certain about their diagnosis with female patients. 
Moreover, results indicate that gender differences in management decisions (therapy and 
lifestyle advice) are less pronounced and less consistent than in diagnostic decisions. 
Magnitude of gender effect on doctors' decisions varies between countries with smaller 
influences in the US. 
Although patients with identical symptoms were presented, primary care doctors’ behavior 
differed by patients' gender in all three countries under study. These gender differences 
suggest that women may be less likely to receive an accurate diagnosis and appropriate 
treatment than men.
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Introduction 
 
The knowledge of gender differences in the morbidity and mortality of coronary heart disease 
(CHD) is well established. (Central Health Monitoring Unit, 1994; Tunstall-Pedoe, Morrison, 
Woodward, Fitzpatrick, & Watt, 1996; Derby, Lapane, Feldman, & Carleton, 2000; National 
Center for Health Statistics, 2005; Statistisches Bundesamt, 2006). These differences are often 
described as results of biological processes and unhealthy lifestyle behaviors that influence 
coronary risk. Estrogens are discussed to have a protective effect for women (Mendelsohn, 
2002; Rossouw et al., 2007). In contrast men’s different health lifestyles could cause a 
coronary illness. Gender specific behaviors (e.g. smoking, high-level alcohol consumption) 
increase the probability of a CHD (Yusuf et al., 2004).  
These gender differences in the prevalence of CHD and risk behavior are well known by most 
general practitioners, yet doctors could hold stereotypical views on what kind of patients are 
at risk for a CHD and those who are not. These views could affect the probability of being 
correctly diagnosed and treated for certain patient groups (Bond et al., 2003; Van Ryn & Fu, 
2003). For example, female patients who are at a lower risk of CHD (overall) are at risk of not 
being diagnosed correctly. Thus, mediated by these stereotypes, non-medical factors could 
affect the doctors’ decision making process and subsequently the therapeutic outcome of a 
patient with symptoms of a CHD (McKinlay, Lin, Freund, & Moskowitz, 2002; Arber et al., 
2004; Anand, Xie, & Metha,2005; Arber et al., 2006; Frich, Malterud, & Fugelli, 2006; 
Mikhail, 2006; Bönte et al., 2007). In research on health disparities the provider behavior 
itself is often unaddressed, though important to understand the development of 
epidemiological gender differences. Furthermore information about gendered care pathways 
in CHD are relatively well documented, but primarily focused on differences within 
secondary care. Raine (2000) provides evidence for the existence of gender bias in the use of 
specialist services by critically appraising the literature. His review indicates that female 
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patients are less likely than male patients to undergo CHD related diagnostic investigations 
and surgical treatment. 
Another limitation of many studies on medical decision making is that they do not control for 
other potential patient factors (like age, ethnicity or social status) or physicians’ attributes 
(like gender and age) that might influence the doctors' decisions (Feldman, Freund, Burns, 
Moskowitz, & Kasten, 1997). In addition, results are often limited to one region or country 
and the role of the health care system in which patients are diagnosed and treated is often not 
taken into account. Comparative research in this field is important to determine the 
contribution of the health care system to health disparities (Blendon, Schoen, DesRoches, 
Osborn, & Zapert, 2003; Herlitz et al., 2003; Blendon et al., 2004; Schoen et al., 2004). In this 
regard, McKinlay et al. (2006) described how doctors in the US and the UK manage the same 
patient. Without analyzing the effect of gender specifically, their results show a high level of 
consistency in medical decision making for coronary heart disease in the two countries. 
However, UK doctors were less certain with the diagnosis and asked more additional 
questions than their US colleagues. Arber et al. (2004; 2006) analyzed the influence of patient 
gender on the decision making process for these two countries together. Findings indicate that 
doctors' diagnostic and management strategies relating to CHD vary by patient gender, to the 
disadvantage of women.  
In this paper gender effects on the diagnosis and treatment of CHD are presented separately 
for three countries with different health insurance systems (a largely private insurance-based 
health care system in the US, a National Health Service government-supported, taxation based 
system in the UK, and a system characterized by decentralized care administered by social 
security agencies in Germany). The aim is to examine if gender disparities in the diagnosis 
and treatment of CHD vary in different health care systems or if they are a cross-national 
invariant phenomenon.  
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Methods 
 
In this study a factorial experimental design with portrayed video vignettes was used 
(Feldman et al., 1997). The aim of the study was to estimate the unconfounded influence of 
patient attributes, physician characteristics and the health care system in which decisions take 
place.  
 
Design and contents of the video vignettes 
To develop the script for the video vignettes clinical consultants role played actual office 
visits. This step was essential to ensure clinical accuracy. Professional actors were used to 
portray medical encounters on videotape in which the 'patient' presented with seven signs and 
symptoms that are typical for CHD including chest pain, pain worsened with exertion, stress 
and eating, relief after resting, discomfort for more than three months, pain through the back 
between the shoulder blades and elevated blood pressure. In addition, a key non-verbal cue 
was incorporated, demonstrated by the 'Levine fist' where the patient clenched his fist to the 
sternum (Marcus et al., 2007). This single script was used for all videotapes presented to the 
physicians. Thus all videotapes have exactly the same text. The patient in the videotapes was 
portrayed as consulting this doctor for the first time with these symptoms.  
The portrayed physicians and patients in the US had American accents, while the very same 
vignette physicians and patients in the UK had British accents. In Germany, the physician and 
patient voices were dubbed by a professional speaker. Professional actors were trained under 
experienced physician supervision to realistically portray a patient presenting the symptoms 
of disease to a primary care provider. Care was taken to construct a culturally neutral set, 
neutral clothes as well as a culture-neutral facial expression. 
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The video was presented to primary care doctors in their practice. Actors on the tapes differed 
according to gender (male vs. female), age (55 vs. 75 years), race (black vs. white) and social 
status (low vs. high) in order to mirror respective patient characteristics. In the present 
analyses we focus on differences between female and male patients.  
 
Instruments 
One CHD-video was presented to each physician. Thereafter, physicians were asked various 
questions regarding diagnosis and treatment in a personal interview with standardized and 
open-ended questions. In terms of diagnostic decision making, the first question was whether 
the physician would ask the patient any additional questions and if so, what kind of 
question(s). Secondly, doctors were asked what they thought was going on with the patient 
and how certain they were with their diagnostic decision. Moreover, physicians were asked to 
name diagnostic tests they would order for this patient. In terms of the management of the 
patient, we wanted to know if they would prescribe or recommend any medication, if they 
would refer the patient to another health care professional and when they would like to see the 
patient again. Finally, physicians were asked if they would recommend any lifestyle advice or 
behavior change.  
 
Physician Sample  
Physicians were randomly selected from lists provided by local health care organizations. 
Selection was made within four strata, defined by combinations of the physicians' gender and 
length of clinical experience (less than 5 years or more than 15 years). To be eligible for 
participation, physicians had to be internists or family practitioners in the US and in Germany 
or general practitioners in the UK. In addition, they had to be working at least half-time and 
had to be trained at an accredited medical school in the country in which they were practicing. 
A letter of invitation was sent to selected doctors who met these criteria. Thereafter, screening 
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telephone calls were conducted to identify eligible physicians and an appointment was 
scheduled for a one-hour long in-person, structured interview conducted in the physician’s 
practice. Each physician subject was provided a modest stipend to partially offset lost revenue 
and to acknowledge their participation. The response rate was 64.9% in the US, 59.6% in the 
UK and 65.0% in Germany. Altogether 384 interviews were conducted in the US 
(Massachusetts) in the UK (the West Midlands, SW London and Surrey) and in Germany 
(North Rhine-Westphalia). The final sample included 64 female and 64 male primary care 
doctors in each country, half of them with less than 5 years of clinical experience, the other 
half with more than 15 years. For a sample size of 128 per country the design has 80% power 
to detect differences of 25 percent. For example, if 25% of physicians would refer a female 
patient to a cardiologist / specialist facility and 50% of physicians would refer a male patient 
to a cardiologist / specialist facility (a difference of 25%) then we would expect to find a 
significant difference (at alpha = 0.05) 80 percent of the time. For a sample size of 384 (all 
three countries), the design has 80% power to detect of difference of 14.5 percent.  
 
Analyses 
Analysis of variance (ANOVA) was used to assess the effect of patients' gender on doctors' 
diagnostic and therapeutic decisions. Because a balanced factorial design was used, the effects 
due to patient gender are un-confounded (orthogonal to) with the other design effects (patient 
age, socioeconomic status and race as well as physician gender and physician level of 
experience). Precise p-values are reported in the tables. Significant results (p<.05) are shown 
in bold. For the data analysis of the open ended questions coding frames were developed and 
answers were summarized into categories (e.g. Antihyperlipidemics, Beta-Blockers, Calcium 
Channel Blockers, Salicylates and Vasodilating Agents were coded as CHD appropriate 
prescriptions). These coding frames were finalised after achieving over 90% inter-coder 
reliability between medical advisers in the three countries.  
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Results 
 
Questioning 
Table 1 shows that women presenting with CHD symptoms would generally receive less 
attention than men. They would be asked fewer questions in the UK and in the US, although 
this gender difference failed to reach statistical significance (p<.05). Moreover, the topics of 
the questions differ between women and men. This especially holds for the UK, where 
significantly more men would have been asked about their medical history, about smoking, 
alcohol consumption, and their psychological state, while significantly more women would 
have been asked about their general health status. In Germany, women are significantly less 
likely to be asked about smoking and alcohol, while in the US gender differences are 
significant only for questions about smoking. Looking at the three countries together, the 
gender differences in all areas of physician's questioning are significant (p<.05).  
 
-Table 1- 
 
CHD diagnosis 
Table 2 shows that CHD was mentioned more often as a possible diagnosis for men than for 
women with a significant gender effect in Germany. In addition, on a scale from 0 (total 
uncertainty) to 100 (total certainty) doctors were significantly more certain of their CHD 
diagnosis with male than with female patients in the UK and in the US. If they mentioned 
CHD as a possible diagnosis, significantly more doctors would order a test for CHD if the 
patient was a man in Germany. Again, looking at the three countries together, all gender 
differences related to the CHD diagnosis are significant at the 5% probability level. 
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-Table 2- 
 
Therapy 
As shown in Table 3, gender differences were also evident in doctors' management decisions. 
In the UK, men would be significantly more likely than women to receive an appropriate 
prescription for possible CHD after the first contact. Moreover, men would be more likely to 
be referred to a cardiologist or a specialist facility in Germany and in the UK. Gender 
difference in days to the next appointment is not significant in any country. Effects of patient's 
gender on therapeutic decisions are non-significant in the US. 
 
-Table 3- 
 
Advice giving 
Doctors were asked if they would give the patient any advice to change their lifestyle 
behavior. Table 4 shows that on average 2.5 pieces of advice would be given to the patient 
across all countries combined. The amount of advice did not vary by gender overall or within  
a given country. Advice about smoking would be given to more male than female patients, 
although this failed to reach statistical significance (p<.05) in each of the three countries. 
There is only one significant difference in advice giving by patients' gender: physicians would 
only recommend reducing weight if the patient was male in Germany.  
 
-Table 4- 
 
 
Discussion 
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This paper focuses on the role of patient gender for clinical decision making in CHD in the 
US, the UK and in Germany. Since vignettes are a valid and comprehensive method for 
measuring the quality of care provided by physicians (Peabody, Luck, Glassman, 
Dresselhaus, & Lee, 2000), a factorial experiment with video vignettes was conducted in the 
three countries. Results show gender differences in the diagnostic strategies of the doctors 
(information seeking, possible diagnosis). Although there are cross-national differences in the 
magnitude indicating strongest effects of gender on doctors' questioning in the UK, a 
consistent general trend can be observed in all countries: Irrespective of identical information 
being presented in the video vignettes, women presenting with CHD symptoms would 
generally receive less questioning than men. In terms of diagnostic decisions, results show a 
consistent tendency: female patients with coronary illness may be less likely to receive an 
accurate diagnosis by primary care doctors in all three countries. Moreover, results indicate 
that differences in therapy decisions (prescription, referrals and lifestyle advices) according to 
patients’ gender are less pronounced and less consistent than in diagnostic decisions.  
Gender differences in physician decision making among patients presenting with symptoms 
of CHD were described earlier (Arber et al., 2004; Arber et al., 2006). Based on this 
knowledge, we have chosen a comparative perspective for our analyses. Although all three 
countries show a similar trend, the magnitude of the gender effect on doctors' decisions varies 
between countries with smaller influences of the patient’s gender in the US. Thus, gender 
differences in the diagnosis and management of CHD seem to be a generalized though not 
invariant phenomenon. Future studies should give more attention to international variations in 
health care disparities to determine the contribution of the health care system to such 
disparities (McKinlay et al., 2006). To improve our understanding of the women's role as well 
as her cultural and socioeconomic status other countries should be included in respective 
studies. 
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Stereotypical beliefs about what kinds of patients are at risk for CHD might influence the 
decision making process (Arber et al., 2004; Adams et al., 2006; Arber et al., 2006; Bönte et 
al., 2007). If those stereotypes are aligned with the knowledge of socio-demographic 
differences in the risk structure of CHD, this strategy could lead to a more precise targeting of 
diagnostic and therapeutic arrangements. But working with standardized videotaped patients, 
where all male and female actors express exactly the same symptoms, treatment differences 
are not indicated. In fact, lower detection rates of CHD amongst female patients could have 
serious consequences for their health. It seems that the epidemiological knowledge of higher 
CHD rates among men could lead the doctors to concentrate their attention on a coronary 
diagnosis among male patients and to under diagnose CHD among women. This assumption 
is supported by the fact that gender differences in the diagnosis of a CHD in the present study 
are more pronounced among midlife patients (55 years) than among older patients (75 years) 
(results not shown). This "gendered ageism" (Arber et al., 2006) can be seen in the context of 
known prevalence and risk profiles. Well known variations in illness rates by gender are 
therefore not only a consequence of differences in the biological or behavioral risk structure, 
but might also be socially constructed (Horton, 2007). In a qualitative work Adams et al. 
(2007) explored sources of gender bias in the decision making process of primary care doctors 
in the UK and the US. During the interviews, that were part of the present study, doctors were 
asked to explain and justify diagnostic and therapeutic decisions for a CHD patient. Findings 
reveal an interaction of physicians’ and patients’ gender. Male doctors appear less affected by 
patient gender but both male and especially female doctors take more account of male 
patients' age and consider more age-related disease possibilities for men than women. It is one 
future task to analyze the qualitative data collected in the present study to provide more 
information on how patient gender affects doctors' cognitive processes during consultations.  
While the rigorous experimental design permits excellent internal validity, external validity 
remains a threat. Several precautionary steps were taken to hopefully minimize this threat. 
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The physicians were specifically instructed to view the patient on the videotape as one of their 
own cases. In addition, the doctors viewed the tapes in the context of their practice day and 
not at a professional meeting, a course update, or in their home. Thus it was likely they 
encountered real patients before and after they viewed the patient in the videotape. To 
enhance the clinical authenticity of the videotaped patient, the script of the vignette was based 
on role plays conducted with skilled physicians. During the production of the videos 
experienced clinicians were present, and only professional and experienced actors were used. 
At the beginning of each interview doctors were asked how typical the videotaped patient was 
compared with patients they see in their practice. In the US, 90.6% of the doctors considered 
them as very or reasonably typical, 91.4% in the UK and 81.3% in Germany. Using Tukey's 
multiple comparisons to test for differences between the three countries we found that rating 
in Germany is significantly (p= 0.0102) lower than in the UK or in the US. The lower rate in 
Germany might be a result of the dubbing that makes the scenario more unrealistic than in the 
two other countries.  
Additionally interviewers were carefully trained and certified and frequent transatlantic 
telephone calls were conducted to ensure standardized interviewing and to minimize 
interviewer variability (Johannes, Crawford, & McKinlay, 1997). Quality control interviews 
and site visits were conducted and selected tape recorded interviews were reviewed by 
supervisors on a regular basis to minimize variation within the three countries. 
However, although substantial effort was devoted to produce the video vignettes as realistic as 
possible, videotapes are not the same as real patients. Diagnostic and therapeutic decisions 
result through the interaction of doctor and patient. This issue could not be addressed in a 
videotape based experiment. In addition, doctors might have viewed the interview as a test. 
This could potentially bias the answers in the direction of social acceptability. To avoid this, 
the doctors were told that the interview is not a test and that there are no right or wrong 
answers.  
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These (potential) limitations are counterbalanced by several strengths of the study. The use of 
a factorial experiment permits simultaneous examination of different types of influence 
(patient, provider and health care system) and allows the estimation of the independent and 
unconfounded effects of the respective factors (e.g. gender of the patient) on clinical decision 
making. Moreover, the design offers the possibility to integrate non-verbal signs like the 
'Levine fist'. Finally, physicians were randomly selected to enhance generalizability.  
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Tables: 
 
Table 1: Gender comparison of the total number and kind of questions physicians would ask the patient by country 
 All three countries Germany UK US     
 Male Female p Male Female p Male Female p Male Female p 
# of questions (mean) 6.2 5.3 .012 3.2 3.0 .676 6.1 5.0 .054 9.4 7.9 .091 
Questions about (%)             
    medical history 66 57 .033 40 38 .685 73 52 .010 84 81 .639 
    smoking 55 29 <.001 28 12 .005 67 30 <.001 69 45 .004 
    alcohol 32 17 <.001 14 2 .014 41 22 .009 41 28 .149 
    psychological state 36 23 .006 23 17 .397 42 23 .032 42 28 .100 
    general health 
status 
54 63 .030 23 38 .054 55 69 .010 83 83 1.000 
p<.05 shown in bold 
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Table2: Gender comparison of correct CHD1 diagnosis, certainty of diagnosis and test ordering for CHD by country 
 All three countries Germany UK US 
 Male Female p Male Female p Male Female p Male Female p 
CHD diagnosis 
(%) 
91 81 .004 81 67 .033 94 83 .076 97 94 .417 
Certainty of CHD 
diagnosis  
(0-100%) 
52 44 .006 41 37 .487 52 40 .028 62 54 .048 
Test for CHD (%) 76 63 .002 48 30 .027 88 73 .065 92 86 .252 
# of tests for CHD 
(mean) 
2.8 2.3 .015 1.1 0.7 .095 4.0 3.1 .073 3.4 3.0 .386 
1 CHD (coronary heart disease) 
p<.05 shown in bold 
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Table 3: Gender differences in the therapy for CHD1 by country 
 CHD (coronary heart disease) 1
 All three countries Germany UK US   
 Male Female p Male Female p Male Female p Male Female p 
CHD 
appropriate 
prescription 
(%) 
50 39 .015 22 12 .139 58 39 .044 70 64 .458 
Referral to a 
cardiologist 
or specialist 
facility (%) 
25 15 .011 27 11 .037 39 23 .037 9 11 .764 
Referral to 
other medical 
professional 
(%) 
33 25 .044 61 42 .027 31 30 .853 8 3 .185 
Days to next 
appointment 
(mean) 
9.6 10.5 .167 4.7 6.8 .080 12.3 14.0 .218 11.8 10.7 .510 
p<.05 shown in bold 
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1 CHD (coronary heart disease) 
 All three countries Germany  UK US 
 Male Female p Male Female p Male Female      p Male Female P 
# pieces of 
advise 
(mean) 
2.5 2.5 .786 1.9 1.8 .780 2.8 3.1 .270 2.9 2.7 .641 
Advice 
about (%) 
            
    diet 52 54 .537 50 52 .858 47 59 .149 58 53 .603 
    smoking 38 26 .004 12 5 .137 62 47 .073 39 25 .088 
    alcohol 21 21 1.000 8 12 .321 36 36 1.000 20 15 .441 
    relaxation 9 7 .578 10 6 .369 11 11 1.000 5 5 1.000 
    weight 5 4 .809 6 0 .049 6 9 .529 2 3 .566 
Table 4: Gender differences in the lifestyle advice for patients with CHD1 by country 
p<.05 shown in bold 
 
 
